1. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model
   Heba Taha et al, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. Deficiency of apoptosis-stimulating protein 2 of p53 protects mice from acute hepatic injury induced by CCl4 via autophagy
   Ping Xu et al, 2019, Toxicology Letters CrossRef
3. ASPP2 inhibits hepatitis B virus replication by preventing nucleus translocation of HSF1 and attenuating the transactivation of ATG7
   Shanshan Wang et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
4. Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice
   Shanshan Wang et al, 2022, Cancer Gene Therapy CrossRef
5. Downregulation of R-Spondin1 Contributes to Mechanical Stretch-Induced Lung Injury
   Chu-Fan Xu et al, 2019, Critical Care Medicine CrossRef
6. Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
   Mubalake Abudoureyimu et al, 2019, Frontiers in Oncology CrossRef
7. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
   Ya Li et al, 2020, Frontiers in Pharmacology CrossRef
8. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs
   Louie Semaan et al, 2021, Oncotarget CrossRef
9. TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities
   Yunfei Huo et al, 2023, Genes & Diseases CrossRef